{
  "id": [
    "25537515"
  ],
  "source": [
    "MED"
  ],
  "pmid": [
    "25537515"
  ],
  "pmcid": [
    "PMC4385860"
  ],
  "title": [
    "Resistance to everolimus driven by epigenetic regulation of MYC in ER+ breast cancers."
  ],
  "authorString": [
    "Bihani T, Ezell SA, Ladd B, Grosskurth SE, Mazzola AM, Pietras M, Reimer C, Zinda M, Fawell S, D'Cruz CM."
  ],
  "authorList": [
    {
      "author": [
        {
          "fullName": [
            "Bihani T"
          ],
          "firstName": [
            "Teeru"
          ],
          "lastName": [
            "Bihani"
          ],
          "initials": [
            "T"
          ],
          "affiliation": [
            "AstraZeneca, R&D Boston, Waltham, MA."
          ]
        },
        {
          "fullName": [
            "Ezell SA"
          ],
          "firstName": [
            "Scott A"
          ],
          "lastName": [
            "Ezell"
          ],
          "initials": [
            "SA"
          ],
          "affiliation": [
            "AstraZeneca, R&D Boston, Waltham, MA."
          ]
        },
        {
          "fullName": [
            "Ladd B"
          ],
          "firstName": [
            "Brendon"
          ],
          "lastName": [
            "Ladd"
          ],
          "initials": [
            "B"
          ],
          "affiliation": [
            "AstraZeneca, R&D Boston, Waltham, MA."
          ]
        },
        {
          "fullName": [
            "Grosskurth SE"
          ],
          "firstName": [
            "Shaun E"
          ],
          "lastName": [
            "Grosskurth"
          ],
          "initials": [
            "SE"
          ],
          "affiliation": [
            "AstraZeneca, R&D Boston, Waltham, MA."
          ]
        },
        {
          "fullName": [
            "Mazzola AM"
          ],
          "firstName": [
            "Anne Marie"
          ],
          "lastName": [
            "Mazzola"
          ],
          "initials": [
            "AM"
          ],
          "affiliation": [
            "AstraZeneca, R&D Boston, Waltham, MA."
          ]
        },
        {
          "fullName": [
            "Pietras M"
          ],
          "firstName": [
            "Mark"
          ],
          "lastName": [
            "Pietras"
          ],
          "initials": [
            "M"
          ],
          "affiliation": [
            "AstraZeneca, R&D Boston, Waltham, MA."
          ]
        },
        {
          "fullName": [
            "Reimer C"
          ],
          "firstName": [
            "Corinne"
          ],
          "lastName": [
            "Reimer"
          ],
          "initials": [
            "C"
          ],
          "affiliation": [
            "AstraZeneca, R&D Boston, Waltham, MA."
          ]
        },
        {
          "fullName": [
            "Zinda M"
          ],
          "firstName": [
            "Michael"
          ],
          "lastName": [
            "Zinda"
          ],
          "initials": [
            "M"
          ],
          "affiliation": [
            "AstraZeneca, R&D Boston, Waltham, MA."
          ]
        },
        {
          "fullName": [
            "Fawell S"
          ],
          "firstName": [
            "Stephen"
          ],
          "lastName": [
            "Fawell"
          ],
          "initials": [
            "S"
          ],
          "affiliation": [
            "AstraZeneca, R&D Boston, Waltham, MA."
          ]
        },
        {
          "fullName": [
            "D'Cruz CM"
          ],
          "firstName": [
            "Celina M"
          ],
          "lastName": [
            "D'Cruz"
          ],
          "initials": [
            "CM"
          ],
          "affiliation": [
            "AstraZeneca, R&D Boston, Waltham, MA."
          ]
        }
      ]
    }
  ],
  "journalInfo": [
    {
      "issue": [
        "4"
      ],
      "volume": [
        "6"
      ],
      "journalIssueId": [
        "2256243"
      ],
      "dateOfPublication": [
        "2015 Feb"
      ],
      "monthOfPublication": [
        "2"
      ],
      "yearOfPublication": [
        "2015"
      ],
      "printPublicationDate": [
        "2015-02-01"
      ],
      "journal": [
        {
          "title": [
            "Oncotarget"
          ],
          "ISOAbbreviation": [
            "Oncotarget"
          ],
          "medlineAbbreviation": [
            "Oncotarget"
          ],
          "NLMid": [
            "101532965"
          ],
          "ESSN": [
            "1949-2553"
          ]
        }
      ]
    }
  ],
  "pubYear": [
    "2015"
  ],
  "pageInfo": [
    "2407-2420"
  ],
  "abstractText": [
    "Acquired resistance to PI3K/mTOR/Akt pathway inhibitors is often associated with compensatory feedback loops involving the activation of oncogenes. Here, we have generated everolimus resistance in ER+ breast cancer cells and in long-term estrogen deprived (LTED) models that mimic progression on anti-estrogens. This allowed us to uncover MYC as a driver of mTOR inhibitor resistance. We demonstrate that both everolimus resistance and acute treatment of everolimus can lead to the upregulation of MYC mRNA, protein expression and, consequently, the enrichment of MYC signatures as revealed by RNA sequencing data. Depletion of MYC resulted in resensitization to everolimus, confirming its functional importance in this setting. Furthermore, ChIP assays demonstrate that MYC upregulation in the everolimus resistant lines is mediated by increased association of the BRD4 transcription factor with the MYC gene. Finally, JQ1, a BRD4 inhibitor combined with everolimus exhibited increased tumor growth inhibition in 3D Matrigel models and an in vivo xenograft model. These data suggest that MYC plays an important role in mediating resistance to everolimus in ER+ and ER+/LTED models. Furthermore, given the regulation ofMYCby BRD4 in this setting, these data have implications for increased therapeutic potential of combining epigenetic agents with mTOR inhibitors to effectively downregulate otherwise difficult to target transcription factors such as MYC."
  ],
  "affiliation": [
    "AstraZeneca, R&D Boston, Waltham, MA."
  ],
  "language": [
    "eng"
  ],
  "pubModel": [
    "Print"
  ],
  "pubTypeList": [
    {
      "pubType": [
        "Journal Article"
      ]
    }
  ],
  "meshHeadingList": [
    {
      "meshHeading": [
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Cell Line, Tumor"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Animals"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Humans"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Mice, Nude"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Breast Neoplasms"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "DT"
                  ],
                  "qualifierName": [
                    "drug therapy"
                  ],
                  "majorTopic_YN": [
                    "Y"
                  ]
                },
                {
                  "abbreviation": [
                    "GE"
                  ],
                  "qualifierName": [
                    "genetics"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                },
                {
                  "abbreviation": [
                    "ME"
                  ],
                  "qualifierName": [
                    "metabolism"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Azepines"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "PD"
                  ],
                  "qualifierName": [
                    "pharmacology"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Triazoles"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "PD"
                  ],
                  "qualifierName": [
                    "pharmacology"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Proto-Oncogene Proteins c-myc"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "GE"
                  ],
                  "qualifierName": [
                    "genetics"
                  ],
                  "majorTopic_YN": [
                    "Y"
                  ]
                },
                {
                  "abbreviation": [
                    "ME"
                  ],
                  "qualifierName": [
                    "metabolism"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Nuclear Proteins"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "AI"
                  ],
                  "qualifierName": [
                    "antagonists & inhibitors"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                },
                {
                  "abbreviation": [
                    "GE"
                  ],
                  "qualifierName": [
                    "genetics"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                },
                {
                  "abbreviation": [
                    "ME"
                  ],
                  "qualifierName": [
                    "metabolism"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Receptors, Estrogen"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "ME"
                  ],
                  "qualifierName": [
                    "metabolism"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Transcription Factors"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "AI"
                  ],
                  "qualifierName": [
                    "antagonists & inhibitors"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                },
                {
                  "abbreviation": [
                    "GE"
                  ],
                  "qualifierName": [
                    "genetics"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                },
                {
                  "abbreviation": [
                    "ME"
                  ],
                  "qualifierName": [
                    "metabolism"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Antineoplastic Agents"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "PD"
                  ],
                  "qualifierName": [
                    "pharmacology"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Immunoblotting"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Tumor Burden"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "DE"
                  ],
                  "qualifierName": [
                    "drug effects"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Xenograft Model Antitumor Assays"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Reverse Transcriptase Polymerase Chain Reaction"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Cell Proliferation"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "DE"
                  ],
                  "qualifierName": [
                    "drug effects"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Epigenesis, Genetic"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "DE"
                  ],
                  "qualifierName": [
                    "drug effects"
                  ],
                  "majorTopic_YN": [
                    "Y"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Gene Expression Regulation, Neoplastic"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "DE"
                  ],
                  "qualifierName": [
                    "drug effects"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "RNA Interference"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Drug Synergism"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Drug Resistance, Neoplasm"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "GE"
                  ],
                  "qualifierName": [
                    "genetics"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Female"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "MCF-7 Cells"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Everolimus"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "PD"
                  ],
                  "qualifierName": [
                    "pharmacology"
                  ],
                  "majorTopic_YN": [
                    "Y"
                  ]
                }
              ]
            }
          ]
        }
      ]
    }
  ],
  "chemicalList": [
    {
      "chemical": [
        {
          "name": [
            "BRD4 protein, human"
          ],
          "registryNumber": [
            "0"
          ]
        },
        {
          "name": [
            "Antineoplastic Agents"
          ],
          "registryNumber": [
            "0"
          ]
        },
        {
          "name": [
            "Receptors, Estrogen"
          ],
          "registryNumber": [
            "0"
          ]
        },
        {
          "name": [
            "Triazoles"
          ],
          "registryNumber": [
            "0"
          ]
        },
        {
          "name": [
            "Azepines"
          ],
          "registryNumber": [
            "0"
          ]
        },
        {
          "name": [
            "Nuclear Proteins"
          ],
          "registryNumber": [
            "0"
          ]
        },
        {
          "name": [
            "Transcription Factors"
          ],
          "registryNumber": [
            "0"
          ]
        },
        {
          "name": [
            "Proto-Oncogene Proteins c-myc"
          ],
          "registryNumber": [
            "0"
          ]
        },
        {
          "name": [
            "(+)-JQ1 compound"
          ],
          "registryNumber": [
            "0"
          ]
        },
        {
          "name": [
            "everolimus"
          ],
          "registryNumber": [
            "9HW64Q8G6G"
          ]
        }
      ]
    }
  ],
  "subsetList": [
    {
      "subset": [
        {
          "code": [
            "IM"
          ],
          "name": [
            "Index Medicus"
          ]
        }
      ]
    }
  ],
  "fullTextUrlList": [
    {
      "fullTextUrl": [
        {
          "availability": [
            "Open access"
          ],
          "availabilityCode": [
            "OA"
          ],
          "documentStyle": [
            "pdf"
          ],
          "site": [
            "Europe_PMC"
          ],
          "url": [
            "http://europepmc.org/articles/PMC4385860?pdf=render"
          ]
        },
        {
          "availability": [
            "Open access"
          ],
          "availabilityCode": [
            "OA"
          ],
          "documentStyle": [
            "html"
          ],
          "site": [
            "Europe_PMC"
          ],
          "url": [
            "http://europepmc.org/articles/PMC4385860"
          ]
        }
      ]
    }
  ],
  "isOpenAccess": [
    "Y"
  ],
  "inEPMC": [
    "Y"
  ],
  "inPMC": [
    "N"
  ],
  "hasPDF": [
    "Y"
  ],
  "hasBook": [
    "N"
  ],
  "hasSuppl": [
    "Y"
  ],
  "citedByCount": [
    "3"
  ],
  "hasReferences": [
    "Y"
  ],
  "hasTextMinedTerms": [
    "Y"
  ],
  "hasDbCrossReferences": [
    "Y"
  ],
  "dbCrossReferenceList": [
    {
      "dbName": [
        "UNIPROT"
      ]
    }
  ],
  "hasLabsLinks": [
    "Y"
  ],
  "license": [
    "cc by"
  ],
  "epmcAuthMan": [
    "N"
  ],
  "hasTMAccessionNumbers": [
    "N"
  ],
  "dateOfCompletion": [
    "2016-01-15"
  ],
  "dateOfCreation": [
    "2015-02-22"
  ],
  "dateOfRevision": [
    "2015-04-16"
  ],
  "firstPublicationDate": [
    "2015-02-01"
  ]
}